Ann C. Moen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ann C. Moen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Chelsey Griffin
National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA
2 shared publications - Jaymin C. Patel
Global Health Center, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA
2 shared publications - Joseph Sewell Bresee
Task Force for Global Health, Decatur, GA 30030, USA
2 shared publications - Julie Garon
Global Health Center, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA
2 shared publications - Kathryn E. Lafond
National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA
2 shared publications - Margaret McCarron
National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA
2 shared publications
Latest Publications
- Open Access
Factors Associated with Intentions to Accept and Recommend Influenza Vaccines Among Healthcare Personnel in a Post-Pandemic Landscape: A Survey in Nine Countries from 2023 to 2024
Background: Although healthcare personnel (HCP) are an essential group for seasonal influenza vaccination, multiple studies show that their vaccine uptake has been minimal in many countries. We explored how the knowledge, attitudes, practices, and perceptions (KAPP) of HCP may contribute to their influenza vaccine uptake and recommendation intentions. Methods: We conducted a cross-sectional KAPP survey of HCP in nine countries in 2023–2024 outside the United States. Pooled data were stratified by the presence or absence of publicly funded influenza vaccination programs for HCP, which was determined by 2014–2022 country-level electronic Joint Reporting Form data. We investigated relationships between participants’ perceptions of and experiences with influenza and its vaccines and their future intentions to receive and recommend them using generalized linear mixed model (GLMM) analyses. Results: Among the 12,296 surveyed HCP from both groups, prior receipt of influenza vaccines was associated with higher likelihood of intention to recommend them ((program: aOR 1.65 (95% CI 1.27, 2.14)) and (no program: aOR 1.85 (95% CI 1.03, 3.32))). There was high intention to receive (86.4%; 4139) and recommend (93.6%; 4486) influenza vaccines in future seasons among the 4792 (39%) participants from countries without influenza vaccination programs, and those believing in the effectiveness of influenza vaccines were more likely to recommend them than those who thought otherwise (aOR 27.74 (95% CI 14.65, 52.52)). Conclusions: There is notably high intention to receive and recommend influenza vaccines among HCP in countries without influenza programs. Addressing barriers to influenza vaccine uptake may contribute to efforts aimed at increasing coverage among this professional population and enhance health security worldwide.
Open AccessFactors Associated with Intentions to Accept and Recommend Influenza Vaccines Among Healthcare Personnel in a Post-Pandemic Landscape: A Survey in Nine Countries from 2023 to 2024
Background: Although healthcare personnel (HCP) are an essential group for seasonal influenza vaccination, multiple studies show that their vaccine uptake has been minimal in many countries. We explored how the knowledge, attitudes, practices, and perceptions (KAPP) of HCP may contribute to their influenza vaccine uptake and recommendation intentions. Methods: We conducted a cross-sectional KAPP survey of HCP in nine countries in 2023–2024 outside the United States. Pooled data were stratified by the presence or absence of publicly funded influenza vaccination programs for HCP, which was determined by 2014–2022 country-level electronic Joint Reporting Form data. We investigated relationships between participants’ perceptions of and experiences with influenza and its vaccines and their future intentions to receive and recommend them using generalized linear mixed model (GLMM) analyses. Results: Among the 12,296 surveyed HCP from both groups, prior receipt of influenza vaccines was associated with higher likelihood of intention to recommend them ((program: aOR 1.65 (95% CI 1.27, 2.14)) and (no program: aOR 1.85 (95% CI 1.03, 3.32))). There was high intention to receive (86.4%; 4139) and recommend (93.6%; 4486) influenza vaccines in future seasons among the 4792 (39%) participants from countries without influenza vaccination programs, and those believing in the effectiveness of influenza vaccines were more likely to recommend them than those who thought otherwise (aOR 27.74 (95% CI 14.65, 52.52)). Conclusions: There is notably high intention to receive and recommend influenza vaccines among HCP in countries without influenza programs. Addressing barriers to influenza vaccine uptake may contribute to efforts aimed at increasing coverage among this professional population and enhance health security worldwide.
- Open Access
Health Worker Influenza Vaccination Programs: A Key to Pandemic Preparedness and Effective COVID-19 Vaccine Deployment in Low- and Middle-Income Countries
Background/Objectives: The COVID-19 pandemic presented an urgent global need to quickly vaccinate health workers (HWs). We used this unique circumstance to assess whether mature influenza vaccination programs for HWs facilitated rapid deployment of COVID-19 vaccines in low- and middle-income countries (LMICs). Methods: We used publicly available population-level COVID-19 vaccination coverage data from the World Health Organization (WHO) COVID-19 PowerBI Dashboard for 60 LMICs to investigate general population coverage with the COVID-19 vaccine over the first year of vaccine rollout. We also evaluated country-level policy and program data reported to the WHO–United Nations Children’s Fund (UNICEF) electronic Joint Reporting Form (eJRF) in 2022 or earlier to determine if the presence of a mature (≥2 years of influenza vaccine introduction in HWs prior to 2019) HW influenza vaccination program was associated with more rapid COVID-19 vaccine deployment and/or pandemic preparedness. We used a mixed-effects beta regression model to investigate whether having a mature HW influenza vaccination program was associated with COVID-19 vaccination coverage levels and/or deployment timeliness. Finally, to provide a better understanding of the possible relationship between the presence of a mature HW influenza vaccination program and the COVID-19 vaccine rollout, we analyzed interview data collected during COVID-19 vaccine post-introduction evaluations (cPIEs). Results: Twenty-four of our study countries (40%) had mature HW influenza vaccination programs prior to the COVID-19 pandemic, and 16 (27%) participated in cPIEs. The overall adjusted mean general-population COVID-19 vaccination coverage at 12 months post-deployment in countries with mature HW influenza vaccination programs was 46% (95% CI: (35%, 56%)), compared with 25% (95% CI: (19%, 32%)) in countries without such programs. Vaccination coverage was 2.5 times higher in countries with mature programs (adjusted odds ratio 2.5, 95% CI: (1.5, 4.5); p = 0.001). Conclusions: Our analysis suggests that mature influenza vaccination programs for HWs were associated with timelier and more complete COVID-19 vaccination rollout.
Open AccessHealth Worker Influenza Vaccination Programs: A Key to Pandemic Preparedness and Effective COVID-19 Vaccine Deployment in Low- and Middle-Income Countries
Background/Objectives: The COVID-19 pandemic presented an urgent global need to quickly vaccinate health workers (HWs). We used this unique circumstance to assess whether mature influenza vaccination programs for HWs facilitated rapid deployment of COVID-19 vaccines in low- and middle-income countries (LMICs). Methods: We used publicly available population-level COVID-19 vaccination coverage data from the World Health Organization (WHO) COVID-19 PowerBI Dashboard for 60 LMICs to investigate general population coverage with the COVID-19 vaccine over the first year of vaccine rollout. We also evaluated country-level policy and program data reported to the WHO–United Nations Children’s Fund (UNICEF) electronic Joint Reporting Form (eJRF) in 2022 or earlier to determine if the presence of a mature (≥2 years of influenza vaccine introduction in HWs prior to 2019) HW influenza vaccination program was associated with more rapid COVID-19 vaccine deployment and/or pandemic preparedness. We used a mixed-effects beta regression model to investigate whether having a mature HW influenza vaccination program was associated with COVID-19 vaccination coverage levels and/or deployment timeliness. Finally, to provide a better understanding of the possible relationship between the presence of a mature HW influenza vaccination program and the COVID-19 vaccine rollout, we analyzed interview data collected during COVID-19 vaccine post-introduction evaluations (cPIEs). Results: Twenty-four of our study countries (40%) had mature HW influenza vaccination programs prior to the COVID-19 pandemic, and 16 (27%) participated in cPIEs. The overall adjusted mean general-population COVID-19 vaccination coverage at 12 months post-deployment in countries with mature HW influenza vaccination programs was 46% (95% CI: (35%, 56%)), compared with 25% (95% CI: (19%, 32%)) in countries without such programs. Vaccination coverage was 2.5 times higher in countries with mature programs (adjusted odds ratio 2.5, 95% CI: (1.5, 4.5); p = 0.001). Conclusions: Our analysis suggests that mature influenza vaccination programs for HWs were associated with timelier and more complete COVID-19 vaccination rollout.